Coya Therapeutics Inc. logo

Coya Therapeutics Inc.

COYA | NASDAQ
Chart Builder DCF Calculator
$4.95
+$0.06 (+1.23%)
At close: Sep 21, 2026, 4:00 PM ET
$4.95
$0 (0.00%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$114.71M
Enterprise Value
$-43.06B
Beta
0.62
Average Volume
178.1K
Shares Outstanding (Diluted)
23.46M
Shares Change YoY
40.25%
Institutional Ownership
35.91%
Exchange
NASDAQ
ISIN
US22407B1089

Price Performance

Price Change 1M
1.2%
Price Change 3M
-8.2%
Price Change 6M
17.9%
Price Change YTD
-12.4%
Price Change 1Y
-9.5%
Price Change 3Y
23.1%
Price Change 5Y
4.5%
1M CAGR (ann.)
6.8%
1Y CAGR (ann.)
-9.6%
5Y CAGR (ann.)
N/A
All-Time CAGR
1.8%

Valuation

PE Ratio
-4.63
Forward PE
N/A
PEG Ratio
-0.43
Forward PEG
-0.57
PS Ratio
14.48
Forward PS
19.50
PB Ratio
0.00
P/FCF Ratio
-0.01
P/Adj. FCF Ratio
-0.01
P/OCF Ratio
-0.01
EV/Sales
-5,370.26
EV/EBIT
1,949.54
EV/EBITDA
1,951.25
EV/FCF
3.15
Earnings Yield
-21.6%
FCF Yield
-11783.1%
Adj. FCF Yield
-14488.8%

Financial Health

Net Cash
$43.18B
Total Debt
$0
Cash & Short-Term Investments
$43.18B
Total Assets
$47.31B
Current Ratio
13.40
Quick Ratio
13.40
Debt / Equity Ratio
0.00
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
N/A
Interest Coverage
0.00
Altman Z-Score
-1.12
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
99.9%
Operating Profit Margin
-282.3%
EBITDA Margin
-275.2%
Net Profit Margin
-270.2%
FCF Margin
-170613.5%
Adj. FCF Margin
-209789.8%
SBC / Revenue
39176.3%
SBC Impact (per share)
-23.0%

Returns

Return on Assets
-0.1%
Return on Equity
-0.2%
Return on Invested Capital
-0.1%
Return on Capital Employed
-0.1%
Return on Tangible Assets
-0.1%

Historical Growth (CAGR)

Revenue CAGR 3Y
-12.8%
Revenue CAGR 5Y
45.7%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
-15.2%
EPS CAGR 5Y
3.3%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-149.7%
FCF CAGR 5Y
-99.7%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
6
EPS Growth Next 3Y
-37.7%
Revenue Growth Next 3Y
-50.0%
Earnings Date
N/A
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$12
Price Target Upside
142.4%

Cash Flow

Operating Cash Flow
$-13.68B
Free Cash Flow
$-13.68B
Adj. Free Cash Flow
$-16.82B
FCF Per Share
-$583.26
OCF Per Share
-$583.30
OCF/S Ratio
-170624.5%

Income Statement

Revenue
$8.02M
Gross Profit
$8.01M
Operating Income
$-22.63M
EBITDA
$-22.07M
Net Income
$-21.67M
EPS (Diluted)
-$1.07
Revenue / Employee
$1M
Profit / Employee
$-2.71M
Employees
8

© 2026 bestshares.com. All rights reserved.